Home > Balance Sheet > VENUS REMEDIES

VENUS REMEDIES
Contingent Liabilities

    Back to Balance Sheet
VENUS REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

VENUS REMEDIES Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹31 Cr₹30 Cr₹40 Cr₹11 Cr₹0.16 Cr

What is the latest Contingent Liabilities ratio of VENUS REMEDIES ?

The latest Contingent Liabilities ratio of VENUS REMEDIES is ₹31 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹31 Cr
Mar2024₹30 Cr
Mar2023₹40 Cr
Mar2022₹11 Cr
Mar2021₹0.16 Cr

How is Contingent Liabilities of VENUS REMEDIES Trending?

Years Contingent Liabilities % Change
Mar2025 ₹31 Cr
0.51
Mar2024 ₹30 Cr
-23.13
Mar2023 ₹40 Cr
272.42
Mar2022 ₹11 Cr
6,423.93
Mar2021 ₹0.16 Cr -

Compare Contingent Liabilities of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹1,226.8 Cr 6.1% 23.9% 212.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,825.0 Cr -1.6% 5.7% 7.7% Stock Analytics
DIVIS LABORATORIES ₹161,535.0 Cr -4.2% -1.4% 9.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,733.0 Cr -2.8% 5.7% 39.3% Stock Analytics
DR REDDYS LABORATORIES ₹107,094.0 Cr -3.2% 1.2% 14.2% Stock Analytics
CIPLA ₹103,513.0 Cr -3.6% -3.7% -10.2% Stock Analytics


VENUS REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

6.1%

23.9%

212.6%

SENSEX

-2.7%

-9.1%

2.6%


You may also like the below Video Courses